Pnc Financial Services Group, Inc. Ultragenyx Pharmaceutical Inc. Transaction History

Pnc Financial Services Group, Inc.

$156 Billion
Q3 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 683 shares of RARE stock, worth $29,812. This represents 0.0% of its overall portfolio holdings.

Number of Shares

683

Previous 498 37.15%

Holding current value

$29,812

Previous $20,000 85.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$40.21 - $59.36 $7,438 - $10,981	185 Added 37.15%	683 $37,000
Q2 2024 Aug 09, 2024	SELL	$37.42 - $51.61 $598 - $825	-16 Reduced 3.11%	498 $20,000
Q1 2024 May 10, 2024	BUY	$43.02 - $53.69 $14,669 - $18,308	341 Added 197.11%	514 $23,000
Q4 2023 Feb 09, 2024	SELL	$31.73 - $49.19 $9,487 - $14,707	-299 Reduced 63.35%	173 $8,000
Q3 2023 Nov 13, 2023	BUY	$34.92 - $46.66 $1,466 - $1,959	42 Added 9.77%	472 $16,000
Q2 2023 Aug 11, 2023	BUY	$37.35 - $52.15 $14,155 - $19,764	379 Added 743.14%	430 $19,000
Q1 2023 May 15, 2023	SELL	$36.99 - $48.71 $6,510 - $8,572	-176 Reduced 77.53%	51 $2,000
Q4 2022 Feb 10, 2023	BUY	$33.72 - $46.33 $1,449 - $1,992	43 Added 23.37%	227 $10,000
Q3 2022 Nov 10, 2022	SELL	$39.96 - $66.14 $799 - $1,322	-20 Reduced 9.8%	184 $7,000
Q2 2022 Aug 12, 2022	SELL	$45.8 - $85.4 $3,938 - $7,344	-86 Reduced 29.66%	204 $12,000
Q1 2022 May 12, 2022	BUY	$62.2 - $84.4 $10,200 - $13,841	164 Added 130.16%	290 $21,000
Q4 2021 Feb 11, 2022	SELL	$73.71 - $87.86 $3,169 - $3,777	-43 Reduced 25.44%	126 $10,000
Q3 2021 Nov 05, 2021	BUY	$77.92 - $102.4 $2,415 - $3,174	31 Added 22.46%	169 $15,000
Q2 2021 Aug 06, 2021	BUY	$92.19 - $115.71 $5,715 - $7,174	62 Added 81.58%	138 $13,000
Q1 2021 May 07, 2021	BUY	$106.9 - $167.73 $3,207 - $5,031	30 Added 65.22%	76 $8,000
Q4 2020 Feb 12, 2021	SELL	$84.4 - $177.39 $6,752 - $14,191	-80 Reduced 63.49%	46 $6,000
Q3 2020 Nov 06, 2020	BUY	$72.98 - $90.0 $2,627 - $3,240	36 Added 40.0%	126 $10,000
Q2 2020 Aug 07, 2020	BUY	$46.91 - $78.22 $4,221 - $7,039	90 New	90 $7,000
Q4 2019 Feb 07, 2020	SELL	$36.08 - $45.83 $682,669 - $867,149	-18,921 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$42.5 - $63.11 $342,932 - $509,234	-8,069 Reduced 29.9%	18,921 $809,000
Q2 2019 Aug 09, 2019	BUY	$54.93 - $74.36 $1.48 Million - $2.01 Million	26,971 Added 141952.62%	26,990 $0
Q1 2019 May 10, 2019	BUY	$39.87 - $69.36 $119 - $208	3 Added 18.75%	19 $0
Q3 2018 Nov 09, 2018	BUY	$71.81 - $90.15 $1,148 - $1,442	16 New	16 $0
Q1 2018 May 11, 2018	SELL	$44.33 - $58.52 $2,260 - $2,984	-51 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$43.54 - $57.32 $2,220 - $2,923	51	51 $0

Others Institutions Holding RARE

# of Institutions

324

Shares Held

85.6M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.06B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Ultragenyx Pharmaceutical Inc. Transaction History